GlassScriptPhysician profile
Stephen J Tentler
NPI 1174542443
$400.61
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $26.73 · 2021: $52.63 · 2022: $217.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $65.40 | 2022 | |
| Triad Life Sciences INC. | $63.28 | 2022 | |
| Smith+Nephew, INC. | $42.53 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $41.88 | 2019 | |
| Alfasigma USA, INC. | $36.32 | 2022 | |
| Stryker Corporation | $34.03 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $32.17 | 2021-2022 | |
| Horizon Therapeutics Plc | $26.18 | 2021 | |
| Orthofix Medical, INC. | $18.06 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.38 | 2022 | |
| Heron Therapeutics, INC. | $13.95 | 2021 | |
| Kci USA, INC. | $12.43 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Tentler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.